Back Stocks profile

Stock analysis tool for investors

Aarti Drugs Ltd.

NSE: AARTIDRUGS | BSE:524348

₹495.90 2.55 (0.52%) 1D

Pharmaceuticals & Biotechnology

View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

494.80

Today’s High

497.80

52W low

409.00

52W High

645.80

Open Price

495.90

Prev. Close

458.7000

Volume

369.00

Value

182987.10

Fundamentals

Market Cap Cr

4559.10

Price to Earnings

25.30

Price to Book Value

3.80

Dividend Yield

0.20

PE to Growth

2.90

Op Revenue TTM Cr

2651.00

Net Profit TTM Cr

180.20

Cash From Operating Activity Cr

134.20

Return on Equity %

13.94

EMA & SMA

Bullish Moving Averages

12

Bearish Moving Averages

4

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

22 Apr, 2024

49.8

Week

44.1

Month

42.3

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

495.35

PIVOT

First Resistance

499.00

Second Resistance

504.65

Third Resistance

508.30

First Support

489.70

Second Support

486.05

Third Support

480.40

Relative Strength Index

54.37

Money Flow Index

82.92

MACD

4.84

MACD Signal

1.71

Average True Range

16.41

Average Directional Index

23.82

Rate of Change (21)

8.92

Rate of Change (125)

-10.95

Commodity Channel Index

58.2

Williams %R

-31.2

BETA

1 Month

0.77

3 Month

1

1 Year

0.54

3 Year

0.37

PRICE CHANGE ANALYSIS

1.08%

1 Week

Low

High

485.55

511.7

8.85%

1 Month

Low

High

431.05

519.15

-7.64%

3 Months

Low

High

431.05

568

-4.35%

6 Months

Low

High

431.05

568

17.16%

1 Year

Low

High

409

645.75

Bigul
19 Apr 2024

AARTI DRUGS LTD. - 524348 - Certificate As Per Regulation 40(9) And 40(10) Of SEBI (LODR) Regulations, 2015

Certificate as per Regulation 40(9) and 40(10) of SEBI (LODR) Regulations, 2015
Bigul
05 Apr 2024

AARTI DRUGS LTD. - 524348 - Compliance Certificate Pursuant To Regulation 7(3) Read With Regulation 7(2) Of The SEBI (LODR) Regulations, 2015 For The Financial Year Ended March 31, 2024.

Compliance Certificate pursuant to Regulation 7(3) read with Regulation 7(2) of SEBI (LODR) Regulations, 2015 for the financial year ended March 31, 2024
Bigul
03 Apr 2024

AARTI DRUGS LTD. - 524348 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2024
Bigul
03 Apr 2024

AARTI DRUGS LTD. - 524348 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Issuance of letter of confirmation in liue of duplicate share certificate
Bigul
30 Mar 2024

AARTI DRUGS LTD. - 524348 - Reconstitution Of Committees

Reconstitution of Committees
Bigul
29 Mar 2024

AARTI DRUGS LTD. - 524348 - Closure of Trading Window

Closure of trading window
Bigul
29 Mar 2024

AARTI DRUGS LTD. - 524348 - Appointment Of Independent Directors

Appointment of Independent Directors
Bigul
29 Mar 2024

AARTI DRUGS LTD. - 524348 - Announcement under Regulation 30 (LODR)-Change in Directorate

Completion of tenure of Independent Director and Appointment of new Independent Directors
See all News

FAQs

The latest market price of Aarti Drugs Ltd. on NSE was Rs. 495.90 as of today.

The opening share price of Aarti Drugs Ltd. was Rs. 495.90 as of today.

The 52-week high share price of Aarti Drugs Ltd. was Rs. 645.80.

The 52 week low share price of Aarti Drugs Ltd. was Rs. 409.00.

Aarti Drugs Ltd. has a market cap of Rs. 4559.10 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Aarti Drugs Ltd. is 2.90. Please refer to the Fundamentals section for further details.

The operating revenue for Aarti Drugs Ltd. in the last FY was Rs.  2651.00 crore. Please refer to the Financials section for further details.

The Net Profit for Aarti Drugs Ltd. in the last FY was Rs. 180.20 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Aarti Drugs Ltd. was on 2024-02-06 for Rs. 1 per share. According to today’s share price, the dividend yield of Aarti Drugs Ltd. stands at 0.20. Please refer to the Corporate Actions section for further details.

The latest bonus issue declared by Aarti Drugs Ltd. was as of 2020-09-30. The bonus ratio declared in this issue was 3:1. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Aarti Drugs Ltd..

Open Account

Let's Open Free Demat Account

Close

Let's Open Free Demat Account